Key Points
- CEO Wayne Williams bought 10,810 shares at $1.70 on Dec. 15, raising his holdings 15.77% to 79,355 shares (about $134,903), according to the SEC filing.
- Callan JMB shows weak fundamentals — shares down ~3.7%, market cap ~$7.9M, trailing EPS of -$0.61, revenue $1.45M for the quarter, and negative net margin (112.72%) and ROE (-133.43%).
- Analysts maintain a consensus "Sell" (Weiss Ratings reiterated "sell (e+)"), even as institutional investor HighTower Advisors recently bought 12,500 shares (~$56,000, 0.28% stake).
Callan JMB Inc. (NASDAQ:CJMB - Get Free Report) CEO Wayne Williams acquired 10,810 shares of the stock in a transaction dated Monday, December 15th. The stock was acquired at an average cost of $1.70 per share, with a total value of $18,377.00. Following the transaction, the chief executive officer owned 79,355 shares of the company's stock, valued at approximately $134,903.50. This trade represents a 15.77% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Callan JMB Trading Down 3.7%
NASDAQ CJMB opened at $1.71 on Tuesday. The business's 50-day moving average price is $3.34 and its 200 day moving average price is $4.34. Callan JMB Inc. has a twelve month low of $1.20 and a twelve month high of $7.76. The company has a market capitalization of $7.90 million and a PE ratio of -1.38.
Callan JMB (NASDAQ:CJMB - Get Free Report) last posted its quarterly earnings data on Friday, November 14th. The company reported ($0.61) EPS for the quarter. The company had revenue of $1.45 million for the quarter. Callan JMB had a negative net margin of 112.72% and a negative return on equity of 133.43%.
Institutional Trading of Callan JMB
An institutional investor recently bought a new position in Callan JMB stock. HighTower Advisors LLC purchased a new stake in Callan JMB Inc. (NASDAQ:CJMB - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 12,500 shares of the company's stock, valued at approximately $56,000. HighTower Advisors LLC owned 0.28% of Callan JMB as of its most recent filing with the Securities & Exchange Commission.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reiterated a "sell (e+)" rating on shares of Callan JMB in a report on Monday, December 8th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has a consensus rating of "Sell".
Check Out Our Latest Research Report on CJMB
Callan JMB Company Profile
(
Get Free Report)
Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
